We have demonstrated that CD27 is expressed on LSCs from CML patients and that triggering of CD27 on LSCs in a murine CML model promotes tumor cell growth and disease progression by activating the Wnt pathway (42). Here, CD27 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.